chr8-139618747-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_StrongBP6_ModerateBP7BA1
The NM_001282534.2(KCNK9):āc.636T>Cā(p.Gly212=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.648 in 1,613,930 control chromosomes in the GnomAD database, including 341,767 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.70 ( 37437 hom., cov: 32)
Exomes š: 0.64 ( 304330 hom. )
Consequence
KCNK9
NM_001282534.2 synonymous
NM_001282534.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.891
Genes affected
KCNK9 (HGNC:6283): (potassium two pore domain channel subfamily K member 9) This gene encodes a protein that contains multiple transmembrane regions and two pore-forming P domains and functions as a pH-dependent potassium channel. Amplification and overexpression of this gene have been observed in several types of human carcinomas. This gene is imprinted in the brain, with preferential expression from the maternal allele. A mutation in this gene was associated with Birk-Barel dysmorphism syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 8-139618747-A-G is Benign according to our data. Variant chr8-139618747-A-G is described in ClinVar as [Benign]. Clinvar id is 1174840.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr8-139618747-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.891 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.841 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNK9 | NM_001282534.2 | c.636T>C | p.Gly212= | synonymous_variant | 2/2 | ENST00000520439.3 | |
KCNK9 | NR_104210.2 | n.767T>C | non_coding_transcript_exon_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNK9 | ENST00000520439.3 | c.636T>C | p.Gly212= | synonymous_variant | 2/2 | 1 | NM_001282534.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.695 AC: 105579AN: 151944Hom.: 37385 Cov.: 32
GnomAD3 genomes
AF:
AC:
105579
AN:
151944
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.656 AC: 164883AN: 251280Hom.: 54702 AF XY: 0.646 AC XY: 87810AN XY: 135846
GnomAD3 exomes
AF:
AC:
164883
AN:
251280
Hom.:
AF XY:
AC XY:
87810
AN XY:
135846
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.643 AC: 940567AN: 1461868Hom.: 304330 Cov.: 78 AF XY: 0.641 AC XY: 466296AN XY: 727240
GnomAD4 exome
AF:
AC:
940567
AN:
1461868
Hom.:
Cov.:
78
AF XY:
AC XY:
466296
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.695 AC: 105688AN: 152062Hom.: 37437 Cov.: 32 AF XY: 0.692 AC XY: 51424AN XY: 74314
GnomAD4 genome
AF:
AC:
105688
AN:
152062
Hom.:
Cov.:
32
AF XY:
AC XY:
51424
AN XY:
74314
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2415
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at